TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.800
+0.250 (5.49%)
At close: Feb 11, 2026, 4:00 PM EST
4.710
-0.090 (-1.87%)
After-hours: Feb 11, 2026, 7:54 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Innovative Drug Delivery Technology and Immune-oncology Therapeutics
18.51M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
18.51M